Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Astellas appoints scientific and medical affairs VP

Astellas appoints scientific and medical affairs VP

9th November 2012

Astellas has announced the appointment of Jeffrey Bloss as vice-president (VP) of its scientific and medical affairs (ASMA) division.

Mr Bloss is a gynaecologic oncologist by specialism and joins the company from GlaxoSmithKline, where he served as VP and head of global medical affairs.

He brings more than a decade of pharmaceutical industry experience to his new role, having previously occupied important positions at companies such as Lilly, Genentech, Onyx Pharmaceuticals and Xenocor.

Astellas president and chief executive Masao Yoshida noted that Mr Bloss joins the organisation at a time when the company has just carried out two major product launches.

He added: "I believe his proven experience in building a strong medical affairs group, excellent leadership and strong collaborative skills will take ASMA and Astellas to the next level."

Last month, the company allied with Japan's National Institute of Advanced Industrial Science and Technology to carry out research into tropical diseases caused by protozoan parasites.ADNFCR-8000103-ID-801485134-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.